Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
ORMP:NASDAQ
Oramed Pharmaceuticals, Inc.
$3.85
+0.26%
(+0.0100) 1D
Apr 24, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ORMP...
Open
$3.84
High
$3.88
Low
$3.77
Mkt. cap
155.72M
Avg. vol.
109.26K
Volume
60.02K
P/E ratio
2.55
52-wk high
$3.96
52-wk low
$1.98
EPS
$1.51
Beta
1.26
Shares outstanding
40.45M
No. of employees
13
News stories
From sources across the web
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.
CEONadav Kidron
Employees13
Founded2006
Headquarters-
SectorPharmaceutical industry
Websiteoramed.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.00M
-
-
-
Cost of goods sold
1.99M
-
-
-
Cost of revenue
1.99M
-
-
-
Research and development expenses
2.21M
1.03M
1.15M
1.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.31M
1.46M
1.27M
3.68M
Operating expense
4.51M
2.49M
2.43M
5.67M
Total operating expenses
6.50M
2.49M
2.43M
5.67M
Operating income
-4.50M
-2.49M
-2.43M
-5.67M
Other non operating income
-
257.00K
408.00K
-313.00K
EBT including unusual items
-7.06M
13.13M
59.45M
9.80M
EBT excluding unusual items
-3.44M
-1.54M
-1.51M
-5.90M
Income tax expense
584.00K
-126.00K
11.06M
-212.00K
Effective tax rate
-8.27%
-0.96%
18.61%
-2.16%
Other operating expenses
-
-
-
-
Net income
-7.64M
13.29M
48.40M
10.01M
Net profit margin
-382.10%
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.06M
689.00K
509.00K
337.00K
Interest expense
-
-
-
-
Net interest expenses
1.06M
689.00K
509.00K
337.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.47M
-2.46M
-2.40M
-5.64M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer